Webinar: Ask the expert with Professor Marcela Votruba
The latest webinar from Retina UK.
Search results
The latest webinar from Retina UK.
SparingVision have announced this week that they have dosed all participants in their phase 1/2 PRODYGY clinical trial for SPVN06, a gene agnostic therapy aimed at slowing disease progression in Retinitis Pigmentosa (RP).
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
Catch up on our BBC Lifeline Appeal from November 2025.
The latest news from Retina UK. Please use the filters to find the articles which interest you.
Are you affected by inherited sight loss? We are here to help.
Mark your special day, whilst fundraising for people with inherited sight loss.
We are proud to work collaboratively with a number of corporate partners to enable our community to live fulfilled lives today as well as supporting the pharmaceutical industry in their mission to develop potential new treatments.
Caryn talks about her experience taking part in the 2021 Virtual London Marathon.